Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus

REFERENCES

• Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trend in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum. 1999;42: 46–50.
   Google Scholar
• Swaak AJ, van den Brink HG, Aarden LA. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol. 1996; 25(4):233–8.
   PubMed Web of Science ®Google Scholar
• Lane NE. Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006; 2(10):562–9.
   PubMedGoogle Scholar
• Gordon C. Long-term complications of systemic lupus erythe-matosus. Rheumatology (Oxford). 2002;41:1095–100.
   PubMed Web of Science ®Google Scholar
• Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in sys-temic lupus erythematosus and the role of steroids. J Rheumatol. 1997;24:1922–9.
   PubMed Web of Science ®Google Scholar
• Redlich K, Ziegler S, Kiener HP, Spitzauser S, Stohlawetz P, Bernecker P, et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:308–10.
   PubMed Web of Science ®Google Scholar
• Bhattoa HP, Bettembuck P, Balogh A, Szitzauer S, Kiss E. Bone mineral density in women with systemic lupus erythematosus. Clin Rheumatol. 2002;21:135–41.
   Google Scholar
• Sinigaglia L, Varenna M, BineIli L, Zucchi F, Ghiringhella D, Gallazzi M, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol. 1999;26:1280–4.
   PubMed Web of Science ®Google Scholar
• Uaratanawrong S, Deesomchoke U, Lertmaharit S, Uaratana-wrong S. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol. 2003;30:2365–8.
   Google Scholar
• Borba VZC, Matos PG, da Silva Viana PR, Fernandes A, Sato El, Lazaretti-Castro M. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus. 2005;14:529.
   Google Scholar
• Bultink IEM, Lems WF, Kostense PJ, Dijkmans BAC, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythe-matosus. Arthritis Rheum. 2005;54:2044–50.
   Google Scholar
• Almehed K, Hetenyi S, Ohlsson C, Carlsten H, Forsblad-d'Elia H. Prevalence and risk factors of vertebral compression fractures in female SLE patients. Arthritis Res Ther. 2010;12:R153.
   Google Scholar
• Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, Mufioz-Guarneros M, Escárcega RO, Jiménez-hernández M, et al. Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol. 2009;28:579–85.
   PubMed Web of Science ®Google Scholar
• Ramsay-Goldman R, Dunn JE, Huang C-F, Dunlop D, Rairie JE, Fitzgerald S, et al. Frequency of fractures in women with sys-temic lupus erythematosus: comparison with United States pop-ulation data. Arthritis Rheum. 1999;42:882–90.
   Google Scholar
• Weistein RS. Glucocorticoid-induced osteoporosis. Rev Endocr Metab Disord. 2001;2:65–73.
   PubMedGoogle Scholar
• Canalis E, Bilezikian JP, Angefi A, Giustina A. Prospectives on glucocorticoid-induced osteoporosis. Bone. 2004;34:593–8.
   PubMed Web of Science ®Google Scholar
• Black DM, Arden NK, Palermo L, Pearson J, Cummings SR; the Study of Osteoporotic Fractures Research Group. Prevalent ver-tebral deformities predict hip and new vertebral deformities but not wrist fractures. J Bone Miner Res. 1999;14:821–8.
   Google Scholar
• Hasserius R, Karlsson MK, Nisson BE, Redlund-Johnell I, Joh-nell 0. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Sweden cohort in the European Vertebral Osteoporosis Study. Osteoporos Int. 2003;14: 61–8.
   Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythe-matosus (letter). Arthritis Rheum. 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from SCr. Nephron. 1976;16:31.
   PubMed Web of Science ®Google Scholar
• Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543–6.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH; the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35:630–40.
   PubMed Web of Science ®Google Scholar
• Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137–48.
   PubMed Web of Science ®Google Scholar
• Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, et al. High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol. 2009; 36:1646–52.
   PubMed Web of Science ®Google Scholar
• Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD. Fujiwara S, et al. A comparison of hip fracture incidence among native Japanese, Japanese American, and American Caucasians. Am J Epidemiol. 1991;133:801–9.
   Google Scholar
• Hagino H, Yamamoto K, Ohshiro H, Nakamura T, Kishimoto H, Nose T. Changing incidence of hip, distal radius, and proximal humerus fracture in Tottori prefecture. Jpn Bine. 1999;24:265–70.
   PubMed Web of Science ®Google Scholar
• Ross RD, Fujiwara S, Huang C, Davis JW, Epstein RS, Wasnich RD, et al. Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol. 1995;24:1171–7.
   PubMed Web of Science ®Google Scholar
• Kobayashi J. On geographical relationship between the chemical nature of river water and death-rate from apoplexy. Berichte des Ohara Instituts fur landwirt-schaftliche Biologie. 1957;11:12–21.
   Google Scholar
• Ministry of Health, Labour and Welfare. The report of National Health and Nutrition Survey of Japan. 2008.
   Google Scholar
• Tang NL, Liao CD, Ching JK, Suen EW, Chan IH, et al. Sex-specific effect of pirin gene on bone mineral density in a cohort of 4000 Chinese. Bone. 2010;46:543–50.
   PubMed Web of Science ®Google Scholar
• Mizunuma H, Shiraki M, Shintani M, Gorai I, Makita K, Itoga S, et al. Randomized trial comparing low-dose hormone replace-ment therapy and HRT plus lalpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss. J Bone Miner Metab. 2006;24(1):11–5.
   PubMed Web of Science ®Google Scholar
• Wu XP, Liao EY, Huang G, Dai RC, Zhang H. A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese, Japanese, and American Cauca-sian women. Calcif Tissue Int. 2003;73(2):122–32.
   Google Scholar
• Kwok AWL, Leung JCS, Chan AYH, Au BSK, Lau EMC, Yurianto H, et al. Prevalence of vertebral fracture in Asian men and women: comparison between Hong Kong, Thailand, Indo-nesia and Japan. Public Health. 2012;126:523–31.
   PubMed Web of Science ®Google Scholar
• Ruyssen-Witrand A, Gossec L, Kolta S. Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a sys-tematic literature review. Osteoporos Int. 2007;18:1271–8.
   Google Scholar
• Gärdsell P, Johnell 0, Nilsson BE. Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int. 1989; 44:235–42.
   Google Scholar
• Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804–9.
   Google Scholar
• Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at dif-ferent skeletal sites. J Bone Miner Res. 1993;8:1227–33.
   Google Scholar
• Huang C, Ross PD, Fujiwara S, Davis JW, Epstein RS, Kodama K, et al. Determinant of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii. Bone. 1996;18:437–42.
   PubMed Web of Science ®Google Scholar
• LoCasio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani D, et al. Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 1990;8:39–51.
   PubMedGoogle Scholar
• Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N, et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 1990;5:1211–6.
   PubMed Web of Science ®Google Scholar
• Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, et al. Prevention of corticosteroid osteoporosis-a comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993;328:1747–52.
   PubMed Web of Science ®Google Scholar
• Saito JK, Davis JW, Wasnich RD, Ross PD. Users of low-dose glucocorticoids have increased bone loss rates: a longitudinal study. Calcif Tissue Int. 1995;57:115–9.
   PubMed Web of Science ®Google Scholar
• van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777–87.
   PubMed Web of Science ®Google Scholar
• Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sam-brook PN. Vertebral fracture risk with log-term corticosteroid therapy: prevalence and relation to age, bone density, and corti-costeroid use. Arch Intern Med. 2000;160:2917–22.
   Google Scholar
• Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving glucocorticoid therapy: a cross-sectional outpatient study. Bone. 2006;39:253–9.
   PubMed Web of Science ®Google Scholar
• Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest. 1998;102:274–82.
   PubMed Web of Science ®Google Scholar
• Andrade F, Casciola-Rosen L, Rosen A. Apoptosis in systemic lupus erythematosus. Clinical implications. Rheum Dis North Am. 2000;26:215–27.
   PubMed Web of Science ®Google Scholar
• Klotbuecher CM, Ross PD, Landswan PB, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721–39.
   PubMed Web of Science ®Google Scholar
• Clarita V, Odvina JE, Zerwekh D, Sudhaker R, Nairn M, Frank A, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Bone Miner Res. 2005;90:1294–301.
   Google Scholar
• Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006;296: 2027–38.
   Web of Science ®Google Scholar
• Hamack L, Stang J, Story M. Soft drink consumption among US children and adolescents. J Am Diet Assoc. 1999;99:436–41.
   Google Scholar
• Wyshak G, Frisch RE. Carbonated beverages, dietary calcium, the dietary calcium/phosphorus ratio, and bone fractures in girls and boys. J Adolesc Health. 1994;15:210–5.
   PubMed Web of Science ®Google Scholar
• Heaney R, Recker R. Effects of nitrogen, phosphorus, and caf-feine on calcium balance in women. J Lab Clin Med. 1982;99:46–52.
   PubMed Web of Science ®Google Scholar
• Heaney RP, Rafferty K. Carbonated beverages and urinary cal-cium excretion. Am J Clin Nutr. 2001;74:343–7.
   PubMed Web of Science ®Google Scholar
• Heaney RP. Effects of caffeine on bone and the calcium econ-omy. Food Chem Toxicol. 2002;40:1263-70,7.
   Google Scholar
• Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism and bone. J Nutr. 1993;123:1611–4.
   PubMed Web of Science ®Google Scholar
• Hallstrom T, Wolk A, Glynn A, Michaelsson K. Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int. 2006;17:1055–64.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Chang J, Edelstein S. Coffee-associated oste-oporosis offset by daily milk consumption. The Rancho Bernardo Study. JAMA. 1994;271:280–3.
   Google Scholar
• Harris S, Dawson-Hughes B. Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr. 1994;60:573–8.
   PubMed Web of Science ®Google Scholar
• Ilich JZ, Brownbill RA, Tamborini L, Cmcevic-Orlic Z. To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? J Am Coll Nutr. 2002;21:536–44.
   Google Scholar
• Bauer D, Browner W, Cauley J, Orwoll E, Scott J, Black D, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657–65.
   PubMed Web of Science ®Google Scholar
• Lloyd T, Schaeffere JM, Walker MA, Demers LM. Urinary hormonal concentrations and spinal bone densities of premeno-pausal vegetarian and nonvegetarian women. Am J Clin Nutr. 1991;54:1005–10.
   PubMed Web of Science ®Google Scholar
• Barger-Lux MJ, Heaney RP, Stegman MR. Effects of moderate caffeine intake on the calcium economy of premenopausal women. Am J Clin Nutr. 1990;52:722–5.
   Google Scholar
• Curatolo PW, Robertson D. The health consequences of caffeine. Ann Intern Med. 1983;98:641–53.
   PubMed Web of Science ®Google Scholar
• Hagarty VH, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr. 2000;71:1003–7.
   Google Scholar
• Sakamoto W, Nishihira K, Iizuka T, Handa H, Ozaki M, Yukawa S. Effect of coffee consumption on bone metabolism. Bone. 2001;28:332–6.
   PubMed Web of Science ®Google Scholar